![](/wp-content/uploads/2022/01/Other-Research-Resources-440x300-1.png")
Latest News
October 26, 2022
October 20, 2022
Posts
;
At yesterday's opening ceremony, we asked the cancer community to stand together to make their voices heard in support of innovative cancer science and medicine. #CancerResearchSavesLives® #AACR25
ICYMI - literally every speaker acknowledges the amazing leadership, power, passion, + friendship of @AACR_CEO, Dr. Marge Foti.
Her transformative leadership has grown @AACR over decades from a small org. to the international powerhouse it is today. #inspirational #AACR25
Incredible panel of journalists across multiple media formats awarded the #AACR25 June L. Biedler Prize for outstanding contributions to Cancer Journalism. Powerful global stories about the successes + challenges in #cancer care! @AACR @AACR_CEO
About Us
The ECOG-ACRIN Cancer Research Group is a strong network of nearly 1400 academic and community-based cancer centers and hospitals in the United States and around the world. We design and conduct biomarker-driven research involving adults who have or are at risk of developing cancer. Learn More
Scientific Pursuits
We are dedicated to improving life for adults affected by cancer. Through our member sites, we are pursuing a robust clinical and translational research portfolio that focuses on precision oncology, immunotherapy, reducing over-treatment and over-diagnosis, leveraging novel biomarker platforms to inform therapeutic decision-making, and advancing standards of care in broad populations of cancer patients and those at risk. Learn More
ECOG-ACRIN by the Numbers
40
Active Clinical Trials
1400
Participating Institutions
67
International Sites
21000
Individual Members
Scientifically rigorous, broadly multidisciplinary, organizationally robust, and internationally respected, the Group is a vibrant component of the National Cancer Institute (NCI) National Clinical Trials Network (NCTN). In addition, we are a Research Base in the NCI Community Oncology Research Program (NCORP).
